LIVN Q2 2025 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$353M+10.7% YoY

Gross Profit

$239M67.8% margin

Operating Income

$54M15.4% margin

Net Income

$27M7.7% margin

EPS (Diluted)

$0.50

QoQ Revenue Growth

+11.3%

Cash Flow

Operating Cash Flow

$63M

Free Cash Flow

$48M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$1.4B

Stockholders' Equity

$1.1B

Cash & Equivalents

$594M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$353M	$319M	+10.7%
Gross Profit	$239M	$215M	+11.2%
Operating Income	$54M	$40M	+34.9%
Net Income	$27M	$16M	+66.3%

Revenue Segments

Cardiopulmonary Segment

$199M57%

Neuromodulation Segment

$152M43%

Geographic Segments

UNITED STATES

$188M53%

Locations Excluding The United States And Europe

$97M28%

Europe

$67M19%